1. Determination of the "in-house interassay precision profile curve" (9) . Five serum pools with TSH concentrations corresponding to the subnormal (at least two pools) and normal range are included in eight to 10 consecutive routine assays to assess the precision actually achieved by a laboratory over the normal and subnormal range.
2. Graphical assessment of the "inhouse lower limit of interassay quantitative measurement" or "lower limit of the assay working range" under routine conditions: this is determined from the intercept of the interassay CV (y-axis) equal to 10% or 15% with the "in-house interassay precision profile" curve.
3. Determination of the "in-house reference range" for euthyroid individuals. 4 . Assay classification: an assay can justifiably be called "sensitive" and doserves further clinical trials in hyperthyroid patients if and only if the "lower limit of quantitative measurement" falls clearly below the normal range. Or, in other words, a clear-cut, complete separation of hyperthyroid and euthyroid TSH values can be achieved only if the inherent sensitivity of the TSH assay and the technical expertise of the laboratory staff are such that TSH concentrations below the normal reference interval are still reproducible with a CV of <15%.
For instance, the enzyme iminunoassay (EIA) from Abbott Laboratories as performed in our laboratory under routine conditions met the fundamental requirement for a "sensitive assay" (Figure 1) , and subsequent clinical investigations have confirmed that initial conclusion. By contrast, various other TSH assays, also designated by their manufacturers as "sensitive," have failed in our hands to meet the criteria, suggesting that they cannot be used to diagnose hyperthyroidism. Solutions of pyridoxal phosphate, 10 mg/L in various solvents (see Table 1 ), were exposed to the following light at a distance of 175 cm for 21 h: four unshielded "cool-white" fluorescent tubes, the same tubes with translucent plastic shielding, four 40-W low-ultraviolet fluorescent tubes, and four "gold fluorescent" tubes. The illumination striking the pyridoxal phosphate solutions from each source (measured with a General Electric type 214 light meter) was 366, 430, 452, and 355 Lx, respectively.
11.
For each trial we placed 1 mL of each pyridoxal phosphate solution in a lowactinic glass test tube as a control and 1 mL in clear test tubes, in triplicate. The low-actinic glass minimized photodecomposition under all lighting conditions and served as a control for chemical decomposition. All tubes were stoppered, placed in wire racks, and exposed to light in a windowless room for 21 h at room temperature. The absorbance was read before and after exposure at the wavelength of the maximum ultraviolet absorption (Table 1). The pyridoxal phosphate concentration in each sample was also determined by liquid chromatography (4) . In accord with the negative-feedback regulation of secretion of thyrotropin (TSH) by the thyroid hormones, TSH production is suppressed (or stimulated) in states of increased (or decreased) thyroid function. A sensitive TSH assay is therefore useful in differentiating normal, thyrotoxic, and hypothyroid patients and in assessing the efficacy of treatments of patients with abnormal thyroid conditions (1).
Some manufacturers have used an immunoradiometric assay (nuA) technique in kits that are highly sensitive for TSH assay, several of which have been evaluated: Boots-Celltech Sucrosep IRMA-TSH (2, 3), TSH3MAIA clone (4-6), Tandem-R TSH (7), Delfia hH (8) , Abbott TSH-EIA (9), and Enzymun-Test TSH (10). I used the TSH3MAIA clone kit product (Serono Diagnostics, Braintree, MA) to assay more than 2500 patients' samples be- Unfortunately, erroneous TSH results for a few patients' samples, noticed in this and another laboratory (6), prevented me from using this assay as a first-line test for thyroid function and led me to evaluate a different product, a solid-phase TSH IRI kit (Pacific Biotech, Inc., San Diego, CA). The assay sensitivity of this product is stated by the manufacturer to be 0.03 millimt. unitfL. Between-assay We have been satisfied with the comparability of the two assay procedures in most cases. However, we observed discrepant results for sera from several patients, two of whom are shown in Table 1 . Patient A. M., a 75-year-old woman in the Home Care Unit of this hospital, who had abovenormal results for T4 and T3 uptake tests in sera on three occasions, had a TSH concentration in serum that far exceeded 50 milli-int. unitsfL as determined with the TSH3MAIA clone kit. To validate this TSH value, we diluted the patients sample and re-assayed, but found no parallelism between the TSH values for the original and diluted serum, indicating the presence of an interfering factor(s). This sample was stored at -20 #{176}C and reassayed 11 months later with both kits. The TSH3MAIA clone kit gave equivalent of 22.3 milli-int. units/L, significantly lower than the value determined previously but still far greater than the TSH concentration for a normal individual. The Pacific Biotech kit, however, gave a TSH value of 0.1 milli-int. unitJL.
Patient G. A., a thyrotoxic 69-yearold woman, showed between normal and borderline increased concentrations of TSH by TSH3MAIA clone procedure, and no parallelism of results was demonstrated in diluted and original serum drawn on September 15.
